Medtech InsightThe global market for orthobiologics for musculoskeletal soft tissue replacement and regeneration is expected to reach $2.3bn by 2023, with a compound annual growth rate (CAGR) of 4.0%, according to "
In VivoIN VITRO DIAGNOSTICS Financings HTG Molecular Diagnostics Inc. HTG Molecular Diagnostics Inc. netted $37.9mm through a public offering of 13.9mm common shares (including the overallotment) at $2.9
In VivoIN VITRO DIAGNOSTICS Financings Cancer Genetics Inc. Molecular diagnostics firm Cancer Genetics Inc. entered a financing agreement with Aspire Capital, through which Aspire will purchase, over the
Medtech InsightThe global market for orthobiologic products used in musculoskeletal soft tissue replacement and regeneration is expected to expand at a compound annual growth rate of 5.9% to reach $1.4bn by 2021. Ac